Qatar Service Agreement - DO NOT USE


STEM CELL STORAGE AGREEMENT

This Stem Cell Storage Agreement is a Contract that has been developed between “CELLSAVE” and the “Client” which sets out the
General Terms and Conditions by which CELLSAVE and the Client will cover all aspects of the Parties› agreement.

This is a very important document, which the Client should read through carefully. Client has to complete the Contract as described
below. A copy will be emailed to the client for their own reference/record.

This document consists of the following sections:

A. SERVICE AGREEMENT
B. INFORMED CONSENT
C. FEE SCHEDULE

SERVICE AGREEMENT

• As per American Association of Blood Banks (AABB) and International Standards, this form should be signed before the
   birth of your baby.
• Complete all parts of this form. This includes your full details, clinic/hospital, physician/midwife, delivery due date, details for
   multiple births (if applicable), and loyalty reduction for returning clients (if applicable).
• It is important that we have the Clients’ full name as per the passport.

INFORMED CONSENT

• As per AABB and International Standards, this form should be signed before the birth of your
baby.
• Complete all parts of this form.This form gives us the consent for Cord Blood, Cord Tissue,
and/or (if applicable) Placental Tissue, Amnion Placental Tissue and Cord Vessel collection.
• It is important that we have the Clients’ full name as per the passport.

FEE SCHEDULE

• This form provides the summary of fees payable.

A. SERVICE AGREEMENT

For the processing, testing, cryopreservation and storage of
Cord Blood Stem Cells and/or (if applicable)
Cord Tissue/Placental Tissue/ Amnion Placental Tissue / Cord Vessel, between

CELLSAVE a CSG-BIO SA company, a company with limited liability registered, existing and operating under the laws of Switzerland;
Having its registered office at Rue de Hesse 12,1204 Geneva, Switzerland;

(Here in after referred to as “CELLSAVE”).

And

The Parent(s)/Legal Guardian(s) listed below on their behalf and the behalf of the (unborn) Child
(Hereinafter jointly to be referred to as the “Client” or the “Clients”)

(CELLSAVE and the Client, together, the “Parties”)

(Client to fill in the relevant fields below)

 

MOTHER/LEGAL GUARDIAN

Last Maiden Name :

First Name:

Address:

Country :

City :

Postal Code:

Date of Birth :

Telephone :

Mobile :

Email Address :

 

FATHER/LEGAL GUARDIAN

Last  Name :

First Name :

Address :  

Country :

City:                                         

Postal Code:

Date of Birth:

Telephone :

Mobile:

Email Address:

 

CLINIC/HOSPITAL

Name :

Address:

City:

Country:

 

PHYSICIAN

Last Name :

First Name:

Address:

City:

 

MIDWIFE

Last Name :

First Name:

Address:

City:

Due Date for Delivery :

Multiple Births Expected

    If Yes, how many?   

Reference number(s) of previous child:  

Service choice:

I (We), the undersigned Parent(s)/ and /or Legal Guardian(s) hereby confirm the following specific Service from CELLSAVE:

 

Where did you hear about us?  

 

B. INFORMED CONSENT

I/We on behalf of my/our unborn child wish to enroll in the Umbilical Cord Blood and Cord Tissue (and/or, if applicable, Placental Tissue/
Amnion Placental Tissue /Cord Vessel) banking service offered by CELLSAVE. The Specimen will be uniquely identified, stored, and
maintained at a cryogenic storage facility. CELLSAVE will retrieve these cells at my/our request as per the Service Agreement. I/ We
agree to its terms of understanding as outlined below, and consent to have the Service preformed.

I/We understand that collection and storing my/our newborn’s Stem Cells may potentially benefit my/our child should he or she need
them in the future to treat certain diseases. I/We understand that it is not possible to determine whether my/our child will develop a
disease in the future that can be treated with these cells. I/We understand that these newborn Stem Cells are a perfect match for my/
our child and, while there is no guarantee my/our child will ever need them, the fact that they are a perfect match can reduce serious
complications should cell therapy ever be needed. I/We understand that my child’s cells may be suitable for use by other family members.

I/We understand that, although infrequent, complications may occur at birth, and it may not be possible to collect Cord Blood and
Cord Tissue (and/or, if applicable, Placental Tissue/ Amnion Placental Tissue /Cord Vessel) from my/our child. Therefore, collection of
Cord Blood and Cord Tissue (and/or, if applicable, Placental Tissue/ Amnion Placental Tissue /Cord Vessel) from my/our child cannot be
guaranteed as its collection is arranged between my/our physician/midwife and me/us. My/Our health and the health of my/our baby is
my/our physician/midwife’s first priority. I/We agree that my/our physician/midwife’s judgment shall be absolute and final.

I/We understand that CELLSAVE will perform cell viability, cell counts, blood typing, and bacterial and fungal tests on the Cord Blood
and Cord Tissue (and/or, if applicable, Placental Tissue/ Amnion Placental Tissue /Cord Vessel) to determine the nature and quality of
the Cord Blood and Cord Blood (and/or, if applicable, Placental Tissue/ Amnion Placental Tissue /Cord Vessel). I/We understand that
regulatory and accreditation associations require certain tests and I/we fully consent to providing the Maternal Blood Test. I/We consent
to the use of a sample from the blood of the mother of the Child to be tested for certain infectious diseases [including, but not limited to,
human immunodeficiency virus (HIV), human T-lymphotropic virus (HTLV), hepatitis B and hepatitis C viruses, cytomegalovirus (CMV),
and syphilis]. This is in accordance with the American Association of Blood Banks (A A BB), EU and International Directives› guidelines
for tissue banks.

I/We understand that if the test results of the sample are confirmed positive for HIV, the Cord Blood and Cord Tissue (and/or, if applicable,
Placental Tissue/ Amnion Placental Tissue /Cord Vessel) will not be stored. I/We understand that if the tests indicate the possible
presence of hepatitis B or C, syphilis, or if my responses to the health questionnaire indicate a risk of one of these infections, my/our
Child’s Cord Blood and Cord Tissue (and/or, if applicable, Placental Tissue/ Amnion Placental Tissue /Cord Vessel) will be processed
and cryopreserved only with the approval of the CELLSAVE Medical Director. Based on the review of these results, I/we understand
that CELLSAVE may decide not to permanently store the Cord Blood and Cord Tissue (and/or, if applicable, Placental Tissue/ Amnion
Placental Tissue /Cord Vessel). If this occurs, I/we will be notified in writing of this decision. I/We authorize CELLSAVE to provide me
with test results and to furnish them to my primary physician, my partner or/and to government agencies as only required by law. If the
Maternal Blood Test is positive for one of the infectious diseases tested for, the Client(s) should sign a continuation form provided by
CELLSAVE.

I/We understand that CELLSAVE will follow the country’s regulations and will follow the same regulations for Cord Blood, Cord Tissue,
Placental Tissue, Amnion Placental Tissue, Cord Vessel collection and the Maternal Blood Test. I/We understand that as per the regulations
of the country, CELLSAVE processes and cryopreserves Cord Blood, Cord Tissue, Placental Tissue, Amnion Placental Tissue and Cord
Vessel collected from full term live babies only, and does not process or cryopreserve Cord Blood, Cord Tissue, Placental Tissue, Amnion
Placental Tissue and Cord Vessel collected from an abortus. I/We understand that CELLSAVE collects Cord Blood, Cord Tissue, Placental
Tissue, Amnion Placental Tissue and Cord Vessel only from married couples with a valid marriage certificate as per the regulations of the
country, and that the Client(s) should provide recent photos for both the mother and the father. I/We understand that the Client(s) are
responsible for the barcodes provided to him/her/them and issued by CELLSAVE. I/We understand that the mother and the father are
both responsible for signing the Informed Consent and all the required paper work for CELLSAVE.

C. FEE SCHEDULE

ENROLLMENT FEE:
The initial deposit (the “Enrolment Fee”) is payable before the birth of the child. Upon receipt of the signed Service Agreement by
CELLSAVE, the collection kit will be sent to you. This fee includes the Cord Blood (and/or, if applicable, Cord Tissue) collection kit,
account set-up and administration fee.

PROCESSING AND STORAGE FEE:
The amount of the processing and storage fee (the “Processing Fee” and “Storage Fee”) is dependent on the Service you have
chosen, and is payable prior to the time the Product is collected from the hospital:

 

CryoPlus (Cord Blood and Cord Tissue)

  SAR KWD QAR OMR BHD
Enrollment 4,000 350 4,000 400 400
Processing 10,000 800 10,000 1,000 1,000
Storage 5,000 450 5,000 500 500
TOTAL 19,000 1,600 19,000 1,900 1,900

CryoAdvanced (Cord Blood, Cord Tissue and Placental Tissue)

  SAR KWD QAR OMR BHD
Enrollment 4,500 450 4,500 450 450
Processing 10,000 1,000 10,000 1,000 1,000
Storage 5,500 550 5,500 550 550
TOTAL 20,000 2,000 20,000 2,000 2,000

CryoUltimate (Cord Blood, Cord Tissue, Placental Tissue, Amnion Placental Tissue and Cord Vessel)

  SAR KWD QAR OMR BHD
Enrollment 5,000 500 5,000 500 500
Processing 11,500 1,150 11,500 1,150 1,150
Storage 6,500 650 6,500 650 650
TOTAL 23,000 2,300 23,000 2,300 2,300

The Processing Fee includes the transport, processing, and testing. It also includes the Maternal Blood Test. The Storage Fee
includes storage during the Initial Storage Period.

This Service Agreement may be terminated by written notice with immediate effect by CELLSAVE if CELLSAVE does not receive
the Enrolment, Processing, or Storage Fee within the specified time.
Termination of this Service Agreement will not affect Client’s responsibility for payment in full of all amounts invoiced and of all
additional administrative and legal costs related to collecting the outstanding amounts under this Service Agreement.

 

ADDITIONAL FEES:
Additional fees may be charged if additional testing is required; e.g. because of abnormal laboratory test results.

REFUNDS:

1. If no Specimen arrives at the Unit, independent of the reason why, Client will only have to pay a fixed amount of 50 % to
cover cost incurred thus far. This means that the Enrolment Fee, reduced by this fixed amount, will be reimbursed. Collection
kit must be returned to CELLSAVE unopened from its sterile packing. Should the sterile packaging be broken, Enrolment
Fee will not be refunded.
2. In the event that Specimen has been collected, received and processed, yet CELLSAVE reject the sample due to its noncompliance
with regulatory standards, no storage will take place and CELLSAVE will refund the Storage Fee to the Client.
The Enrolment Fee and the Processing Fee is not refundable if the Cord Blood (and/or, if applicable, Cord Tissue/Placental
Tissue/Amnion Placental Tissue/Cord Vessel) Specimen has been processed and tested.
3. In the event that any part of a client package is not processed, the client is only responsible for paying for the components
that are successfully processed and stored. If any component of your package is not processed, the client will not be
responsible for paying for these components and any costs paid will be reimbursed as per the terms and conditions of this
agreement. Refer to the table below.

Processed and/or stored

  Only One Service Only Two Services Only Three Services
Enrollment 3,500 3,500 4,000
Processing 9,000 10,000 10,000
Storage 3,500 5,000 5,500
TOTAL 16,000 18,500 19,500

 

SPECIAL REDUCTIONS:
A returning Client is eligible for the loyalty reduction of QR 2,000 of the Processing Fee of the Cord Blood when saving Stem Cells
of a subsequent new-born Child with CELLSAVE.
In case of twins, Client is entitled to receive QR 5,000 reduction on the Total Fee of the Service for the second Child.
A combination of these two reduction offers is not possible.

 

PAYMENT OPTIONS:
Please check option(s) below for payments of the fees as outlined in schedule C:

All payments must be received and cleared at time specified in the Fee Schedule (Section C). In the event of failure to meet this
requirement, even in relation to a single invoice, the Client shall be obliged to pay the entire outstanding balance due in one single
instalment. Should the Client fail to do so, the Service Agreement may be terminated by CELLSAVE in accordance with section 6
of the General Terms and conditions. The storage certificate will only be released after full payment has been received and cleared.

 

GENERAL TERMS AND CONDITIONS

1. PURPOSE:
The purpose of this document is to set out the terms, conditions, limitation, risks and costs of the processing, testing, cryopreservation
and storage in an authorized cellular processing and storage unit and release of the Product (as defined below) obtained from the
Specimen (as defined below) collected at the time of birth of the Child (as defined below) of the Client.

In this Service Agreement, the following definitions shall have the following meaning:

 

Terminology

Term Definition
Amnion Placental Tissue It’s the thin and elastic membrane lining the inside of the placental sac, this unique tissue has a long history of topical wound healing, and it’s therapeutic benefits continue to be identified and it’s uses continue to grow.
   
Child Any child identified by the Client in the Informed Consent in Section B;
   
Cord Blood Blood collected from the umbilical cord and placenta of the Child following delivery.
   
Cord Tissue Tissue taken from the umbilical cord of the Child following delivery.
   
Cord Vessel Cell types that lines the Cord Tissue taken from the Child following delivery
   
Enrolment Fee The meaning ascribed to it in the Fee Schedule in Section C;
   
Extended Storage Period The meaning ascribed to it in Section 6;
   
Fees The meaning ascribed to it in Section 4;
   
Informed Consent The consent attached to this service agreement under which the client gives their informed consent to the storage of the specimen
   
Initial Storage Period The meaning ascribed to it in Section 6;
   
Maternal Blood Test Tests which must be undertaken on the blood of the mother of the child (as identified and approved in the Informed Consent in Section B) to assess whether the Specimen is suitable for storage in accordance with international and local guidelines and regulations and as otherwise required there under;
   
Medical and Health History Profile The questionnaire completed by the Client and attached to this Service Agreement, under which the Client provides CELLSAVE with certain information about his/her/their Medical health history booklet;
   
Processing Fee The meaning ascribed to it in the Fee Schedule in Section C;
   
Placental Tissue The meaning ascribed to it in the Fee Schedule in Section C;
   
Storage Fee The meaning ascribed to it in the Fee Schedule in Section C;
   
Product In the event that CryoPlus Service is elected the cryopreserved Cord Blood Stem Cells and the cryopreserved Cord Tissue (and, in the event that the CryoAdvanced Service is elected, the cryopreserved Cord Blood Stem Cells, the cryopreserved Cord Tissue, Placental Tissue), (and, in the event that the CryoUltimate Service is elected, the cryopreserved Cord Blood Stem Cells, the cryopreserved Cord Tissue, Placental Tissue, Amnion Placental Tissue and the Cord Vessel);
   
Release Form The meaning ascribed to it in Section 8;
   
Service The processing, storage and associated services to be provided by CELLSAVE under the service agreement in respect of the product (which may include the CryoPlus, CryoAdvanced or CryoUltimate)
   
Service Agreement This service agreement between the Client and CELLSAVE which shall include the Service Agreement in Section A, the general terms and conditions, the informed consent in Section B, the medical health history profile booklet and the fee schedule in section C;
   
Specimen The Cord Blood and Cord Tissue (and in the event that the CryoAdvanced Service is elected, the cord blood, cord tissue placental tissue), (and in the event that the CryoUltimate Service is elected, the cord blood, the cord tissue, cord vessel and placental tissue, Amnion Placental Tissue and the cord vessel).
   
Stem Cells The stem cells extracted from the cord blood
   
Unit The meaning ascribed to it above

 

By signing this Service Agreement, the Client agrees to be legally bound to CELLSAVE for the processing, testing, cryopreservation and storage of the Specimen in any Unit. The Client also acknowledges that he/she/they has/have been fully informed, and accept(s) and agree(s) to the conditions, risks, limitations and associated costs of such activities, in accordance with these terms and conditions.

2. SERVICES OF CELLSAVE:
CELLSAVE’s obligations and liabilities are expressly limited to the services described in this Service Agreement; no other services will
be provided by CELLSAVE to the Client and CELLSAVE expressly disclaims any responsibility to provide any other services other than
the ones stated in this Service Agreement.

CELLSAVE will not put the Specimen to use for any purpose other than to enable CELLSAVE to provide the Service to the Client as
per this Service Agreement.

If the Client elects to use the CELLSAVE services the following provisions shall apply:

On receipt of the Specimen, CELLSAVE will use best endeavors to process and cryo-preserve Stem Cells from the Specimen for
the purpose of direct application in humans, provided a sufficient number of viable Stem Cells as per its acceptance criteria can
be identified. CELLSAVE will store the Product for the Initial Storage Period (as defined in Section 6 below) or longer as agreed in
accordance with Section 6.

In the event, after processing has commenced, there are insufficient Stem Cells in the Product or CELLSAVE is unable to harvest
collected Stem Cells from the Specimen or if CELLSAVE determines that storage for other reasons is not possible (the Specimen is
damaged or contaminated), no storage will take place and refunds will be as stipulated in section C of the Fee schedule.

In the event where processing has not taken place due reasons such as Specimen is received by CELLSAVE more than 72 hours after
the birth of the Child, or the collected Specimen volume is too small refunds will be as stipulated in section C of the Fee schedule.

With respect to Cord Tissue, on receipt of the Specimen, CELLSAVE will use best endeavors to prepare it for cryopreservation and
storage. In the event that the Cord Tissue has not been collected following the instructions, or if CELLSAVE determines that storage
is for other reasons not possible (e.g. the Specimen is received by CELLSAVE more than 72 hours after the birth of the Child; the
Specimen is damaged or contaminated), refunds will be as stipulated in section C of the Fee schedule.

If the sample/unit is being used for a transplant within 5 years (from the date of delivery of the baby), CELLSAVE will give the client a
“transplant assistance” valued at 15,000 QR.

3. RESPONSIBILITIES OF CLIENT:
Client agrees to complete all necessary forms accurately and in a timely manner as CELLSAVE may from time to time reasonably
consider as required or deemed beneficial to the Service in view of applicable legislation or industry standards.

Client is responsible for arranging the collection of the Specimen by the physician, obstetrician or other medical staff at the birth of the
Child as per the instructions received from CELLSAVE. It is the responsibility of the Client to either contact CELLSAVE or the courier
company designated by CELLSAVE after the Specimen has been collected.

CELLSAVE will arrange for transport of the Specimen to the CELLSAVE designated Unit, on the Client’s behalf, immediately after
having received notification by the Client of the collection of the Specimen by the physician, obstetrician or other medical staff at the
birth of the Child. CELLSAVE expressly excludes all liability for the collection of the Specimen by the physician, obstetrician or other
medical staff at the birth of the Child. CELLSAVE expressly excludes all liability for the transportation of the Specimen if done by a
third party.

Client agrees to act at all times in accordance with all applicable local legislation and regulations, and will be responsible for obtaining
all necessary documents and permits if so, required for the collection and export of the Specimen to the Unit.

4. FEES AND PAYMENT:
The fee for the Service (the “Fee”) and the payment conditions applicable to the Service are laid down in the Fee Schedule in Section
C. The Fee consists of a non-refundable Enrolment Fee and a Processing and Storage Fee and certain other fees, in each case as
further described in the Fee Schedule in Section C. Client agrees to pay the Fees on time and in accordance with the Fee Schedule
in Section C.

If there is more than one Client, Clients shall be jointly and severally liable for the payment of the invoiced fees.

5. STORAGE:
The Specimen and Product will be processed, tested, cryopreserved and stored in accordance with the following terms

a. CELLSAVE stores the Product in an authorized Unit. The Cord Blood Product will be split and stored in two physically separate
locations. The preferred locations should be requested on email to info@CELLSAVE.com after successful storage confirmation.
b. CELLSAVE may assign and transfer any or all of its rights and obligations under this Service Agreement to any third party, for
which the Client hereby gives consent. CELLSAVE will notify the Client in writing to that effect.
c. CELLSAVE does not give, nor does it purport to give, any medical advice, or otherwise perform any other function for the
Client other than the services expressly described in this Service Agreement.
d. Client hereby consents to the collection, transport and testing of the Specimen and to the processing, cryopreservation and
storage of the Specimen in and to a Unit as stated by this Service Agreement.
e. The Client’s right to storage and release of the Product is subject to the timely and full payment of all Fees by the Client in
accordance with this Service Agreement.

Storage Options

6. TERMS AND TERMINATION:
These terms and conditions come into force on the date of receipt by CELLSAVE of the Service Agreement signed by the Client, and
will continue for a period of 30 years from the date of the birth of the Child (the “Initial Storage Period”).

Six months prior to the end of the Initial Storage Period, an agreement can be made upon the mutual agreement of the Parties in
the event that Client wishes CELLSAVE to continue to store the Product on their behalf for a further period (the “Extended Storage
Period”), and such extended storage shall be at the market prices valid at that time. If 30 days before the expiry of this Service
Agreement, Parties have not agreed the terms of an Extended Storage Period of the Product, or upon termination of this Service
Agreement by CELLSAVE or the Client in accordance with this Clause 6, Client relinquishes all rights in and waives all rights to the
Product and CELLSAVE shall have the right to destroy the Product.

This Service Agreement may be terminated prior to its term by written notice with immediate effect:

a. By Client at any time prior to the collection of the Specimen. In this case a minimal Fee will be charged as indicated in the
Fee Schedule in Section C.
b. By CELLSAVE if the Specimen and/or Product are not suitable for storage, whether for medical, safety, practical or any other
reason, as determined by CELLSAVE in its sole and absolute discretion (e.g. the Specimen is received by CELLSAVE more than
72 hours after the birth of the Child; the Specimen is damaged; the collected Specimen volume is too small). In these situations,
CELLSAVE will not store the Specimen and/or Product. CELLSAVE retains the sole right to make this decision.
c. By CELLSAVE if CELLSAVE does not receive the Enrolment Fee and/or Processing and Storage Fee within the specified time.

Termination of this Service Agreement under clause 6c above will not affect Client’s responsibility for payment in full of all amounts
invoiced and of all additional administrative and legal costs related to collecting the outstanding amounts. On termination of this
Service Agreement, CELLSAVE reserves the right to destroy the Specimen and/or the Product.

7. RIGHTS TO PRODUCT:
Unless otherwise defined by applicable law, the Product remains the property of the Child throughout the term of this Agreement.
Until the Child reaches legal age, the Client has the right and responsibility to consent to the collection, storage, use and disposal of
the Product on behalf of the Child.

8. RELEASE REQUEST:
In the event that the Product is required for treatment or manufacturing of a medicinal product, the Client shall provide written
notification of the same to CELLSAVE. Any request for release has to be addressed to CELLSAVE SA, Rue de Hesse 12, 1204 Geneva,
Switzerland and to the attention of the General Manager, or to the e-mail address info@CELLSAVE.com. The notice shall include the
name and address of the physician and hospital to which the Product must be sent or the appropriately accredited Current Good
Manufacturing Practices ( cGMP) manufacturer. CELLSAVE shall then provide the authorised hospital or manufacturer with a release
form (the “Release Form”) which must be returned to CELLSAVE. CELLSAVE will arrange for transport of the Product to the hospital,
on the Client’s behalf.
CELLSAVE expressly excludes all liability for the transportation of the Product conducted by a third party.

CELLSAVE will not charge the Client any costs involved with the transport of the Product to the destination indicated on the Release
Form.

9. ACKNOWLEDGEMENT:
The Client understands that the actual collection of the Specimen by the physician, obstetrician or other medical staff at the birth of
the Child is not part of the Service and that the relevant doctor, obstetrician or other medical staff may under certain circumstances
refuse, be unable or fail to collect and/or adequately pack the Specimen and that neither CELLSAVE nor its officers, shareholders,
employees, agents and contractors bear any responsibility for any mistakes or damages caused by such doctor, obstetrician or other
medical staff.

The Client also understands and confirms that CELLSAVE, its officers, directors, employees, shareholders, agents and consultants
have not made any representations and bear no responsibilities and obligations with respect to the possibility to collect Stem Cells
successfully from the Specimen, the suitability of the Stem Cells for the contemplated treatment, the successful treatment of any
diseases through Stem Cell transplantation or therapies, and the advantages of umbilical cord blood Stem Cell usage over other
therapies using Stem Cells.

10. LIMITATION OF LIABILITY:
CELLSAVE’s responsibility towards the Client and/or the Child whose Product are being stored is limited to the Service described in
this Service agreement. Client agrees that should he/she/they make any claim against CELLSAVE, CELLSAVE’s liability shall, to the
extent allowed under applicable law, regardless of the basis of such claim, whether in contract, tort or otherwise, be limited in total
and in aggregate to ( a) the amount of the Fee paid by the Client to CELLSAVE under this Service Agreement, or ( b) in the event
of CELLSAVE’s negligence, the amount permitted to be recovered by CELLSAVE under the malpractice insurance maintained by
CELLSAVE in connection with such claims.

11. DATA PROTECTION:
Client agrees to the processing and storage of personal data (including personal data of the Child and the mother and father of the
Child), by CELLSAVE or its agent, affiliate or subcontractor, which has come to CELLSAVE’s knowledge in the course of performing
the Services and otherwise under this Service Agreement. Client agrees and permits CELLSAVE to inform the status of infectious
disease report of the mother of the Child and the Cord Blood and Cord Tissue and/or Amnion Placental Tissue/Cord Vessel to any
other agency mandated under the country’s laws or under any other law to which CELLSAVE is subject.

CELLSAVE will use Client’s personal data only to the extent required by its contractual obligations hereunder and in accordance with
the applicable laws and regulations of the country.

12. FORCE MAJEURE:
CELLSAVE cannot be held liable for, and expressly excludes all liability for, any possible loss or damage due to natural disasters, act of
war or terror, riot, strike, vandalism, acts or omission of authorities or any events beyond CELLSAVE ‘s control which cause destruction
of, or deterioration to the Specimen and/or Product.

13. NOTICE:
If the Client needs to send CELLSAVE any notices or communications under the Service Agreement, the Client must send them in
writing by first class or registered post/recorded delivery to the CELLSAVE address as set out in Section 13 below or any alternative
address that CELLSAVE notifies to the Client.

If CELLSAVE needs to send the Client any notices or communications under the Service Agreement CELLSAVE will send them in
writing by first class or registered post/recorded delivery to the Client’s address as notified by the Client to CELLSAVE on page 1.The
Client shall as soon as possible notify CELLSAVE in writing of any changes in the information provided, including relocation and/or
change of address. All notifications to CELLSAVE shall be sent to: CELLSAVE SA, Rue de Hesse 12, 1204 Geneva, Switzerland, or to
the e-mail address: info@CELLSAVE.com. CELLSAVE may completely rely on the data made available in writing by the Client, without
any obligation to make further inquiries with respect to the correctness or actuality of such data.

14. COMPLIANCE WITH U.A.E. LAWS AND REGULATIONS:
CELLSAVE operates and exists in the Switzerland and thus is required to comply with the laws of the country and the regulatory and
legal requirements
of governmental agencies. The Client hereby agrees that CELLSAVE may take any action required by it in order to comply with the
laws of the country.

15. GOVERNING LAW:
This Service Agreement shall be governed by, and construed in accordance with, the laws of Switzerland. The Parties may bring suit
in any court of competent jurisdiction.

16. HEADINGS:
The headings contained in this Service Agreement are for reference purposes only and shall not affect the meaning or interpretation
of this Service Agreement.

17. SEVERABILTY:
Should any provision of this Service Agreement be invalid or unenforceable or should this Service Agreement contain an omission,
the remaining provisions shall remain valid. In the place of an invalid provision or an omission, a new, valid provision –which comes
economically closest to the one actually agreed upon provision or, in the event of an omission, the intentions set forth in this Service
Agreement – is presumed to be agreed upon by the Parties.

18. ENTIRE AGREEMENT:
This Service Agreement constitutes the entire understanding between the Parties with respect to the subject matter of this Service
Agreement and supersedes all prior agreements, negotiations and discussions between the Parties relating to it.

19. AMENDMENT:
Neither Party can change or amend the terms of this Service Agreement without the prior written approval of the other Party.

 

Please tick below to agree.

 

Please enter your Full Name and Email Address to receive a copy of agreement.

Leave this empty:

Signature arrow sign here


Signature Certificate
Document name: Qatar Service Agreement - DO NOT USE
lock iconUnique Document ID: 7acb23d61f2d8d462c4f6c9d6ab99654b32c7e84
Timestamp Audit
August 18, 2023 12:11 pm +04Qatar Service Agreement - DO NOT USE Uploaded by Cellsave Arabia - csait@cellsave.com IP 5.32.48.90
Audit trial Qr code
This audit trail report provides a detailed record of the online activity and events recorded for this document.
https://cellsave.com/
Audit Trail Serial# 0a4297cf2edc7e53a03b02b3577c6bd4